EyeWorld Asia-Pacific June 2019 Issue

EWAP JUNE 2019 £Î FEATURE A ««ÀœÛ> œv ̅i 6ˆÃˆ>˜ /œÀˆV “«>˜Ì>Li œ>“iÀ i˜Ã ] -/ƂƂ, -ÕÀ}ˆV>] œ˜ÀœÛˆ>] >ˆvœÀ˜ˆ>® ˆ˜ ̅i 1°-° }ˆÛià ÀivÀ>V̈Ûi ÃÕÀ}iœ˜Ã another option to correct high “Þœ«ˆ> >˜` >Ã̈}“>̈Ó° /…i ̜ÀˆV Ü>à >««ÀœÛi` LÞ Ì…i 1°-° œœ` >˜` ÀÕ} Ƃ`“ˆ˜ˆÃÌÀ>̈œ˜ ˆ˜ -i«Ìi“LiÀ œv >ÃÌ Þi>À >˜` LiV>“i >Û>ˆ>Li ̜ ÃÕÀ}iœ˜Ã ˆ˜ ̅i v>° º7i…>Ûi Lii˜ >˜ÝˆœÕÃÞ >Ü>ˆÌˆ˜} ̅i >««ÀœÛ> vœÀ “>˜Þ Þi>ÀÃ]» Ã>ˆ` Lance Kugler, MD , "“>…>] iLÀ>Î>° ivœÀi ̅i >««ÀœÛ>] ̅i ÌÞ«ˆV> ÃÕÀ}ˆV> œ«Ìˆœ˜ vœÀ À° Õ}iÀ½Ã «>̈i˜Ìà ܈̅…ˆ}…“Þœ«ˆ> >˜` >Ã̈}“>̈Ó Ü>à ÌÀi>̈˜} ̅i “Þœ«ˆ> ܈̅>˜ >˜` ̅i >Ã̈}“>̈Ó ܈̅ a corneal procedure such as Ƃ- ° ƂÌ…œÕ}…ivviV̈Ûi] º“>˜Þ «>̈i˜Ìà >Ài ˜œÌ V>˜`ˆ`>Ìià vœÀ Ƃ- ] >˜` ̅i ÃÌ>}i` «ÀœVi`ÕÀi >``à œ}ˆÃ̈V> Vœ“«i݈ÌÞ] Ü >˜ all-in-one solution is a welcome addition to our vision correction ÃÕÀ}ˆV> œ«Ìˆœ˜Ã°» º iˆ˜} >Li ̜ VœÀÀiVÌ “Þœ«ˆ> >˜` >Ã̈}“>̈Ó ܈̅> «…>ŽˆV " `œià ˜œÌ Vœ“«Àœ“ˆÃi ̅i ˆ˜Ìi}ÀˆÌÞ œv ̅i VœÀ˜i>] `œià ˜œÌ ˆ˜`ÕVi `ÀÞ iÞi] >˜` }ˆÛià iÝVii˜Ì >˜` ÃÌ>Li µÕ>ˆÌÞ œv ۈȜ˜]» Ã>ˆ` Erik Mertens, MD , i`ˆ«œˆÃ] Ƃ˜ÌÜiÀ«] i}ˆÕ“° Best candidates 1°-°‡L>Ãi` ÃÕÀ}iœ˜Ã >Ài Ã̈ ÌÜi>Žˆ˜} ̅iˆÀ ÀiVœ““i˜`>̈œ˜Ã vœÀ ܅œ ˆÃ LiÃÌ ÃՈÌi` vœÀ ̅i i˜Ã° Paul Dougherty, MD , Vˆ˜ˆV> ˆ˜ÃÌÀÕV̜À] Տià -Ìiˆ˜ Þi ˜Ã̈ÌÕÌi] 1˜ˆÛiÀÈÌÞ œv >ˆvœÀ˜ˆ>] œÃ Ƃ˜}iiÃ] w˜`à ̅>Ì Ì…i LiÃÌ V>˜`ˆ`>Ìià vœÀ ̅i ̜ÀˆV >Ài ̅œÃi ܈̅“œÀi ̅>˜ > `ˆœ«ÌiÀ œv Vޏˆ˜`iÀ >˜` > ÀivÀ>V̈œ˜ œv “œÀi ̅>˜ qn ° º ̅ˆ˜Ž «>̈i˜Ìà ܅œ >Ài > qn Li˜iwÌ vÀœ“ >˜ œÛiÀ Ƃ- LiV>ÕÃi œv ̅i Å>À«iÀ ۈȜ˜] having the correction closer to Making room in the toolbox for the toric ICL by Vanessa Caceres Þi7œÀ` œ˜ÌÀˆLṎ˜} 7ÀˆÌiÀ Now approved in the U.S., toric ICL offers a correction option for high myopes with astigmatism AT A GLANCE • č««ÀœÛ> œv ̅i 6ˆÃˆ>˜ /œÀˆV ˆ˜ ̅i 1°-° «ÀœÛˆ`ià >˜œÌ…iÀ ۈȜ˜ VœÀÀiV̈œ˜ œ«Ìˆœ˜ vœÀ …ˆ}…“Þœ«ià ܈̅>Ã̈}“>̈Ó° • 1Ãi œv ̅i i˜Ã V>˜ «œÌi˜Ìˆ>Þ }ˆÛi > ºÜœÜ» v>V̜À ̜ «>̈i˜Ìà >˜`…i« «ÀœÌiVÌ Ì…i VœÀ˜i>° • -ˆâˆ˜} >˜` >ˆ}˜“i˜Ì ÀiµÕˆÀi `ˆvviÀi˜Ì w˜iÃÃi >˜` ÌiV…˜ˆµÕi ̅>˜ > ÌÀ>`ˆÌˆœ˜> " ° • -ÕÀ}iœ˜Ã ŜՏ` iÌ «>̈i˜Ìà Ž˜œÜ…œÜ ̅iˆÀ ۈÃÕ> µÕ>ˆÌÞ Üˆ Li `ˆvviÀi˜Ì ܈̅̅i ] iëiVˆ>Þ ˆv ̅i «>̈i˜Ì …>à ÕÃi` > ÃViÀ> œÀ }>à «iÀ“i>Li Vœ˜Ì>VÌ i˜Ã LivœÀi° Editors’ note: Drs. Dougherty, Mertens, and Parkhurst have ƂPCPEKCN KPVGTGUVU YKVJ 56##4 5WTIKECN &T -WINGT JCU PQ ƂPCPEKCN interests related to his comments. œ˜Ì>VÌ ˆ˜vœÀ“>̈œ˜ Dougherty: y>«â>«J}“>ˆ°Vœ“ Kugler: ŽÕ}iÀJŽÕ}iÀۈȜ˜°Vœ“ Mertens: ° iÀÌi˜ÃJ“i`ˆ«œˆÃ°Li Parkhurst: }«>ÀŽ…ÕÀÃÌJ«>ÀŽ…ÕÀÃ̘ÕۈȜ˜°Vœ“ Visian ICL. -œÕÀVi\ -/ƂƂ, -ÕÀ}ˆV> This article originally appeared in the March 2019 issue of EyeWorld . It has DGGP UNKIJVN[ OQFKƂGF CPF CRRGCTU here with permission from the ASCRS Ophthalmic Services Corp.